lung adenocarcinomas

Jarushka Naidoo: Mucinous lung adenocarcinomas – clinical features and outcomes

Jarushka Naidoo, Full Professor and Consultant Medical Oncologist at Royal College of Surgeons in Ireland, shared a post on X about Jia Luo et al. published in Annals of Oncology:

“Mucinous lung adenocarcinomas: clinical features and outcomes Annals of Oncology:

  • Of 4082 patients with LUAD, 9.9% LUADMuc
  • associated with low PDL1 expression, low TMB
  • KRAS, NKX2-1, STK11, SMARCA4, GNAS, ALK+ seen
  • poorer PFS, OS and ORR to chemo-IO.”

“Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors”

Authors: Jia Luo et al.

Jarushka Naidoo: Mucinous lung adenocarcinomas - clinical features and outcomes

More posts featuring Jarushka Naidoo.

Annals of Oncology cancer Jarushka Naidoo Jia Luo Mucinous lung adenocarcinomas OncoDaily Oncology